New research may help generate production of blood platelets on demand Dr. Kamal Kant Kohli27 Sept 2022 6:45 AM ISTIncreasing shortages of donor-derived platelet units has promoted researchers to explore alternative methods of meeting with shortage including cell...
Gilead Sciences' Kite gets European Commission nod for CAR T-cell therapy Tecartus Ruchika Sharma8 Sept 2022 4:00 PM ISTSanta Monica, Calif.: Kite, a Gilead Company has announced that the European Commission (EC) has approved its CAR T-cell therapy Tecartus...
Lupin rationalising product portfolio in US to overcome price erosion impact, says CEO Vinita Gupta Ruchika Sharma16 Aug 2022 1:30 PM ISTLupin's transitioning of the portfolio from the simple generic oral solids to complex generics had started with short-acting bronchodilator albuterol.
Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine Dr. Kamal Kant Kohli13 July 2022 8:30 PM ISTPeople with hematologic malignancies-or blood cancers including leukemia, lymphoma, and multiple myeloma-have an impaired immune system due to their...
Roche gets USFDA priority review for Lunsumio to treat relapsed or refractory follicular lymphoma Ruchika Sharma8 July 2022 5:30 PM ISTPriority Review designation is granted to medicines that the FDA considers to have the potential to provide significant improvements in the safety and...
AstraZeneca broadens haematological cancer pipeline with TeneoTwo acquisition Ruchika Sharma6 July 2022 12:30 PM ISTAstraZeneca will acquire all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m on deal closing.
Adult survivors of childhood cancer often undertreated for cardiovascular risk factors Dr. Kamal Kant Kohli28 Jun 2022 4:45 AM ISTDALLAS: Adults who survive childhood cancer have a higher risk of cardiovascular disease than the general population, yet they are 80% more likely to...
New combination therapy found effective for paediatric T-acute leukaemia Dr. Kamal Kant Kohli23 Jun 2022 7:30 PM ISTResearchers at Tampere University's Faculty of Medicine and Health Technology in Finland, the Massachusetts General Research Institute, and the...
Researchers develop hybrid sensor that can help diagnose cancer Dr. Kamal Kant Kohli21 Jun 2022 8:30 AM ISTA team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications...
Prostate cancer linked to increased risk of VTE among men Dr. Kamal Kant Kohli19 Jun 2022 7:30 PM ISTNew research published in the online journal BMJ Open suggests that men with prostate cancer have a 50% higher risk of developing serious and...
Three-drug therapy with autologous stem cell transplant improves survival in multiple myeloma: NEJM Dr. Kamal Kant Kohli15 Jun 2022 8:00 PM ISTResearchers have found in a new study appearing in New England journal of Medicine that among adults with multiple myeloma, RVD plus ASCT was...
PSA prostate cancer screening found more beneficial than previous estimates, especially for blacks Dr. Kamal Kant Kohli13 Jun 2022 8:00 PM ISTNew research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve...
